OVP Venture Partners appeared to be the VC, which was created in 1983. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Seattle.
The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Enterprise Software. Among the various public portfolio startups of the fund, we may underline Cradlepoint, RedSeal, VLST Corporation
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the OVP Venture Partners, startups are often financed by Ignition Partners, Yaletown Partners, Sevin Rosen Funds. The meaningful sponsors for the fund in investment in the same round are Yaletown Partners, GrowthWorks Capital, Amgen Ventures. In the next rounds fund is usually obtained by Ignition Partners, Yaletown Partners, GrowthWorks Capital.
The average startup value when the investment from OVP Venture Partners is 50-100 millions dollars. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The real fund results show that this VC is 14 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2014. Opposing the other organizations, this OVP Venture Partners works on 2 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The overall number of key employees were 3.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Group14 Technologies | $17M | 21 Dec 2020 | Washington, United States | ||
Group14 Technologies | $18M | 09 Aug 2019 | Washington, United States | ||
Symform | $11M | 25 Apr 2012 | Seattle, Washington, United States | ||
$6M | 12 Dec 2011 | Seattle, Washington, United States | |||
Oncofactor | $2M | 02 Aug 2011 | Seattle, Washington, United States | ||
PrecisionDemand | $8M | 29 Jul 2011 | Seattle, Washington, United States | ||
Fate Therapeutics | $36M | 05 May 2011 | San Diego, California, United States | ||
Acylin Therapeutics | $4M | 11 Jan 2011 | Seattle, Washington, United States | ||
CarbonFlow | $4M | 28 Oct 2010 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Group14 Technologies | $17M | 21 Dec 2020 | Washington, United States | ||
Group14 Technologies | $18M | 09 Aug 2019 | Washington, United States | ||
Symform | $11M | 25 Apr 2012 | Seattle, Washington, United States | ||
$6M | 12 Dec 2011 | Seattle, Washington, United States | |||
Oncofactor | $2M | 02 Aug 2011 | Seattle, Washington, United States | ||
PrecisionDemand | $8M | 29 Jul 2011 | Seattle, Washington, United States | ||
Fate Therapeutics | $36M | 05 May 2011 | San Diego, California, United States | ||
Acylin Therapeutics | $4M | 11 Jan 2011 | Seattle, Washington, United States | ||
CarbonFlow | $4M | 28 Oct 2010 | San Francisco, California, United States |